Photodynamic inactivation for controlling Candida albicans infections
FP Gonzales, T Maisch - Fungal biology, 2012 - Elsevier
Antimicrobial photodynamic therapy (APDT) combines a non-toxic dye, termed
photosensitizer, which is activated by visible light of appropriate wavelength which will …
photosensitizer, which is activated by visible light of appropriate wavelength which will …
Traitement antifongique des candidoses systémiques en réanimation
A Kettani, ZH Belkhadir, A Mosadik, M Faroudy… - Journal de mycologie …, 2006 - Elsevier
Résumé Les candidoses systémiques ont connu un essor considérable au cours de cette
dernière décade. Leur mauvais pronostic est lié au retard thérapeutique secondaire à la …
dernière décade. Leur mauvais pronostic est lié au retard thérapeutique secondaire à la …
Therapy of infections in cancer patients
J Klastersky - Supportive Care In Cancer, 1999 - taylorfrancis.com
Fever has long been associated with malignancy and remains a common problem in cancer
patients. With the advent of cytotoxic therapy, fever in the cancer patient has been closely …
patients. With the advent of cytotoxic therapy, fever in the cancer patient has been closely …
Épidémiologie et facteurs de risque des candidoses systémiques en réanimation
R Gauzit - Annales francaises d'anesthesie et de reanimation, 2001 - Elsevier
Résumé Les candidoses systémiques sont de plus en plus fréquentes en réanimation. Les
données épidémiologiques américaines et européennes montrent également lˈémergence …
données épidémiologiques américaines et européennes montrent également lˈémergence …
[HTML][HTML] Systemic mycoses: An overview for modern natural health professionals
R Thiel - The Original Internist, 2010 - healthresearch.com
Systemic mycoses can cause a tremendous variety of health problems including digestive
difficulties (diarrhea, bloating, discomfort, flatulence, constipation, colitis, etc.), skin problems …
difficulties (diarrhea, bloating, discomfort, flatulence, constipation, colitis, etc.), skin problems …
Making the diagnosis of fungal infection: when to start treatment
P Martino, C Girmenia - International journal of antimicrobial agents, 2000 - Elsevier
Fungal infections continue to cause major complications in cancer patients. With the
increasing use of aggressive chemotherapy and stem cell transplantation causing profound …
increasing use of aggressive chemotherapy and stem cell transplantation causing profound …
A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies
S Machard, F Theodoro, H Benech… - Antimicrobial agents …, 2000 - Am Soc Microbiol
Since currently used assays of amphotericin B (AMB) lack sensitivity or are not easily
adaptable in all laboratories, we have developed an enzyme immunoassay for AMB in …
adaptable in all laboratories, we have developed an enzyme immunoassay for AMB in …
Management of invasive fungal infections in oncological patients
H Hebart, C Bokemeyer, J Löffler… - Oncology Research …, 1999 - karger.com
Invasive fungal infections, especially due to Candida and Aspergillus spp., have become a
major cause of infection-related mortality in neutropenic cancer patients. Conventional …
major cause of infection-related mortality in neutropenic cancer patients. Conventional …
Candida: Some Thoughts
N Soni - Yearbook of Intensive Care and Emergency Medicine …, 2000 - Springer
Candida infection as a local problem is well recognized in the normal population but even
more commonly encountered in populations with impaired immune responses and …
more commonly encountered in populations with impaired immune responses and …
Anja Eichner
F Pereira, T Maisch - api.taylorfrancis.com
Photodynamic activity of chemical compounds against microorganisms was first published
more than 100 years ago. Oskar Raab observed that toxicity of acridine hydrochloride …
more than 100 years ago. Oskar Raab observed that toxicity of acridine hydrochloride …